Correlation Between Spyre Therapeutics and Arrow Electronics

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Arrow Electronics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Arrow Electronics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and Arrow Electronics, you can compare the effects of market volatilities on Spyre Therapeutics and Arrow Electronics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Arrow Electronics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Arrow Electronics.

Diversification Opportunities for Spyre Therapeutics and Arrow Electronics

0.63

Correlation Coefficient

Spyre Therapeutics  Arrow Electronics

Poor diversification

The 3 months correlation between Spyre and Arrow is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Arrow Electronics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrow Electronics and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Arrow Electronics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrow Electronics has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Arrow Electronics go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and Arrow Electronics

Given the investment horizon of 90 days Spyre Therapeutics is expected to generate 10.07 times more return on investment than Arrow Electronics. However, Spyre Therapeutics is 10.07 times more volatile than Arrow Electronics. It trades about 0.04 of its potential returns per unit of risk. Arrow Electronics is currently generating about 0.0 per unit of risk. If you would invest  900.00  in Spyre Therapeutics on December 3, 2024 and sell it today you would earn a total of  1,070  from holding Spyre Therapeutics or generate 118.89% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Spyre Therapeutics  vs.  Arrow Electronics

Spyre Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Arrow Electronics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Arrow Electronics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Spyre Therapeutics and Arrow Electronics

The main advantage of trading using opposite Spyre Therapeutics and Arrow Electronics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Arrow Electronics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrow Electronics will offset losses from the drop in Arrow Electronics' long position.

The idea behind Spyre Therapeutics and Arrow Electronics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.